Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.52
-0.28 (-3.18%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Immix Biopharma Employees
As of December 31, 2025, Immix Biopharma had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,665,846
Market Cap
606.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| REGENXBIO | 371 |
| CorMedix | 191 |
| ARS Pharmaceuticals | 159 |
| Allogene Therapeutics | 152 |
| AgomAb Therapeutics NV | 62 |
| Zevra Therapeutics | 61 |
| Tectonic Therapeutic | 60 |
IMMX News
- 4 days ago - Immix Biopharma initiated with a Buy at Needham - TheFly
- 5 days ago - Immix Biopharma Investigated by the Portnoy Law Firm - GlobeNewsWire
- 6 days ago - Immix Biopharma announces termination of CMO Richard Graydon - TheFly
- 6 days ago - Wanted fugitive secretly working at Immix as CMO, STAT reports - TheFly
- 23 days ago - Immix Biopharma Slides: Corporate presentation - Filings
- 5 weeks ago - Immix Biopharma initiated with a Buy at BofA - TheFly
- 5 weeks ago - Immix Biopharma initiated with an Outperform at LifeSci Capital - TheFly
- 5 weeks ago - Immix Biopharma Slides: Corporate presentation - Filings